Adapt Produtos Oftalmológicos Ltda.
5
0
0
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
40.0%
2 terminated/withdrawn out of 5 trials
0.0%
-86.5% vs industry average
100%
5 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Role: lead
Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
Role: lead
Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation
Role: lead
Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Role: lead
Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.
Role: lead
All 5 trials loaded